20
Participants
Start Date
June 27, 2025
Primary Completion Date
March 31, 2027
Study Completion Date
April 30, 2028
Repotrectinib
"Repotrectinib is administered orally in capsule form, with each capsule containing size 0 hard gelatin 40 mg of the active compound in bottles containing 30 capsules.~Repotrectinib is administered orally in the form of capsules. The capsules are taken by mouth and swallowed intact (without chewing, crushing, or opening) with water or another suitable liquid."
RECRUITING
Medizinische Universität Graz, Graz
RECRUITING
Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela
RECRUITING
Hospital Universitario de León, León
RECRUITING
Hospital Beata María Ana, Madrid
RECRUITING
Hospital Universitari Sant Joan de Reus, Reus
RECRUITING
Hospital Clínico Universitario de Valencia, Valencia
RECRUITING
Hospital de Cruces, Barakaldo
RECRUITING
Medical University of Vienna, Vienna
RECRUITING
Hospital de Vinalopó, Elche
RECRUITING
Hospital General Universitario Dr. Balmis, Alicante
RECRUITING
UOMI Cancer Center, Barcelona
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
Medical University of Vienna
OTHER
MedSIR
OTHER